COMPANY
Global bio venture company specializing in cell therapy products
History
Humancellbiois leaping forward as a leading bio company representing Korea.
2018
Company establishment
Standardized Core technology for immune cell culturing completed
2020
Joint research MOU with CHA Univ. for cell research and storage
Pre-clinical trial of NK cell therapy for liver cancer
Patent application for method of culturing NK cells through utilizing the composition NK cell culture
Launched ginseng berry ODF NK JIN
Patent applications for PM CURE
2019
GMP facility completion
Launched immune cell extract cosmetics
Established R&D facility and acquired venture certification
SCOR (DGB/KB Bank)
ISO 9001/14001 Certified
2024
Technology transfer with Vietnam for regenerative therapy
GMP facility approval
Launched ginseng berry ODF MITO JIN
2023
Youth-friendly Hidden Champion certified
Published research results on international journal(Cancers, 2023Jun, 15(12): 3225)
GMP facility expansion(Songdo Techno Park IT center)
Permission for "human cell management business, etc.“
Best family friendly management
2022
Appointed SK Securities for IPO
Selected as R&D company for National Project(KFRM/1.5 billion KRW)
Hidden champion certified
3 Patented technology transfer agreement including tendinopathy treatment using mitochondria with CHA Univ.
2021
Technology licensing with CHA Univ. for the method of mass culturing stem cells
MOU with ZTO Ltd. for overseas business